Restriction fragment length polymorphism analysis reveals different allele frequency and a linkage disequilibrium at locus D1S94 in neuroblastoma patients

European Journal of Cancer

Volumn 33, Issue 12, 1997, Pages 1949-1952

  Perri, P ^d   Pession, A ^d   Mazzocco, K ^a   Scaruffi, P ^a   Strigini, P ^b   Iolascon, A ^d   Albergoni, M P ^d   Basso, G ^c   Tonini, G P ^a  

^a G GASLINI INSTITUTE   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c UNIVERSITY OF TURIN   (Italy)

^d NONE

Author keywords

Allelic frequency; Chromosome 1; D1S112; D1S94; Hardy Weinberg; Linkage disequilibrium; Loss of heterozygosity; MYCN amplification; Neuroblastoma

Indexed keywords

ALLELE; CELLULAR DISTRIBUTION; CHROMOSOME 1; CHROMOSOME LOSS; CONFERENCE PAPER; GENE DELETION; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENETIC SUSCEPTIBILITY; HUMAN; HUMAN TISSUE; NEUROBLASTOMA; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; TUMOR SUPPRESSOR GENE;

ALLELES; CHROMOSOMES, HUMAN, PAIR 1; GENE AMPLIFICATION; GENES, MYC; GENETICS, POPULATION; HUMANS; ITALY; LINKAGE (GENETICS); LOSS OF HETEROZYGOSITY; NEUROBLASTOMA; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PROGNOSIS;

EID: 0031417655     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(97)00286-4     Document Type: Conference Paper

References (21)

1. Schwab M. Molecular cytogenetics of human neuroblastoma. Biochim Biophys Acta. 1114:1992;43-50.
2. Caron H, Peter M, van Sluis P, et al. Evidence for two tumor suppressor loci on chromosomal bands 1p35-36 involved in neuroblastoma: one probably imprinted, another associated with N-myc amplification. Hum Mol Genet 1995, 4, 535-539.
3. Weith A, Martinsson T, Cziepluch C, et al. Neuroblastoma consensus deletion maps to 1p36.1-2. Genes Chrom Cancer 1989, 1, 159-166.
4. Fong CT, Dracopoli NC, White PS, et al. Loss of heterozygosity for short arm of chromosome 1 in human neuroblastomas: correlation with N-myc amplification. Proc Natl Acad Sci USA 1989, 86, 3753-3757.
5. Hunt J. D., Tereba A. Molecular evaluation of abnormalities of short arm of chromosome 1 in neuroblastoma. Genes Chrom Cancer. 2:1990;137-146.
6. Peter M, Michon J, Vielh P, et al. PCR assay for chromosome 1p deletion in small neuroblastoma samples. Int J Cancer 1992, 52, 544-548.
7. Takayama H, Suzuki T, Mugishima H, et al. Deletion mapping of chromosome 1p deletion in small neuroblastoma samples. Oncogene 1992, 7, 1185-1189.
8. Caron H. Allelic loss of chromosome 1 and additional chromosome 17 material are both unfavorable prognostic markers in neuroblastoma. Med Pediatr Oncol. 24:1995;215-221.
9. Takeda O, Homma C, Maseki N, et al. There may be two tumor suppressor genes on chromosome arm 1p closely associated with biologically distinct subtypes of neuroblastoma. Genes Chrom Cancer 1994, 10, 30-39.
10. White PS, Maris JM, Beltinger C, et al. A region of consistent deletion in neuroblastoma maps within human chromosome 1p36.2-36.3. Proc Natl Acad Sci USA 1995, 92, 5520-5524.
11. Tonini G. P. Report of the Italian Pediatric Cancer Research Group on the Neuroblastoma Research Programme. Eur J Cancer. 28A:1993;1000-1001.
12. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning. A Laboratory Manual, 2nd edn. Cold Spring Harbor Laboratory Press, New York, 1989.
13. Southern E. M. Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol. 98:1975;503-517.
14. Martinsson T., Weith A., Cziepluch C., Schwab M. Chromosome 1 deletions in human neuroblastoma: generation and fine mapping of microclones from distal 1p region. Genes Chrom Cancer. 1:1989;67-78.
15. Pearson ES, Hartley HO. Biometrika Tables for Statisticians, vol. 1, 3rd edn. Cambridge University Press, Cambridge, 1966.
16. Kaplan E. L., Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 53:1958;457-481.
17. Mantel N., Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 22:1959;719-748.
18. Sansone R, Strigini P, Badiali M, et al. for the Italian Neuroblastoma Research Program. Age-dependent prognostic significance of N-myc amplification in neuroblastoma: the Italian experience. Cancer Genet Cytogenet 1991, 54, 253-257.
19. Lopez R., Karakousis C., Rao U. Treatment of adult neuroblastoma. Cancer. 45:1980;840-844.
20. Tonini GP, Boni L, Pession A, et al. MYCN oncogene amplification in neuroblastoma is associated with worse prognosis, except in stage 4s. The Italian experience with 295 children. J Clin Oncol 1997, 15(1), 85-93.
21. Peterson AC, Di Rienzo A, Lehesjoki AE, et al. The distribution of linkage disequilibrium over anonymous genome regions. Human Mol Genet 1995, 4, 887-894.